US Patent 7799808 α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom

Patent 7799808 was granted and assigned to NeuroGenetic Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

NeuroGenetic Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7799808

Date of Patent

September 21, 2010

Patent Application Number

11765397

Date Filed

June 19, 2007

Patent Citations Received

‌

US Patent 12071428 Indazole compounds as kinase inhibitors

Patent Primary Examiner

‌

Rei Tsang Shiao

Patent abstract

Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7799808 α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API